Registration Frequencies

Weekly updated frequencies of observation starts at registration by medication are shown.

Fig 1) Patient numbers by biologic treatment at inclusion
Last update: 30. July| total n= 25,747
Fig 1) Patient numbers by biologic treatment at inclusion

 

Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: 30. July| total n= 25,747
Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion

 

Show table for Fig. 1/2Hide table

Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
Adalimumab 1087 1488
Bimekizumab 406 0
Brodalumab 592 0
Certolizumab 237 0
Efalizumab 35 0
Etanercept 312 72
Golimumab 25 0
Guselkumab 1935 0
Infliximab 102 1
Ixekizumab 1053 0
Risankizumab 1951 0
Secukinumab 2153 0
Tildrakizumab 1685 0
Ustekinumab 782 18
Apremilast 780 0
Ciclosporin 402 0
Deucravacitinib 234 0
Fumaric acid esters 2694 0
Dimethyl fumarate 3413 0
Methotrexate 3924 0
Tofacitinib 2 0
Upadacitinib 8 0
other systemics 356 0

 

Fig. 3) Rate of patients by medication class at inclusion
Last update: 30. July| total n= 25,747
Fig. 3) Rate of patients by medication class at inclusion

 

Fig. 4) Rate of patients by type of registry site
Last update: 30. July| total n= 25,747
Fig. 4) Rate of patients by type of registry site

 

Fig. 5) Registered PsoBest centers
Last update: 16. July| n= 1,199 | updated monthly
Fig. 5) Registered PsoBest centers